How PET scan sugar behaves in cancer
Treatments studied
Part of Cancer clinical trials.
This study looks at how a PET scan's tracer (a radioactive sugar) behaves in normal organs and in cancer. It may help doctors better understand scan results for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a cancer diagnosis
- You must be scheduled for a PET scan at the nuclear medicine unit
- You cannot have a lung infection or other active inflammation that could affect the scan results
- You cannot have cancer that has spread extensively to major organs (like the liver, lungs, or bones)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET/CT scan to learn more about lymphoma in adults. The scan may help doctors better understand your cancer and guide treatment decisions.
This study looks at different ways to measure the brightness of tumors on PET/CT scans. It aims to find which method is most accurate, which could improve how doctors read scans and plan treatment.
This study checks whether a specific analysis method (called FUR) can better measure how much “sugar” from PET scans is used by tumors. It uses regular PET/CT scans you may already get as part of standard care, and compares how the measurements work.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
This study tests a new type of PET scan (a special imaging test) called 18F-FGIn to help doctors better detect and evaluate cancers. It may be more accurate than the standard PET scan for certain tumors like brain, liver, stomach, and colon cancers.
Hear when a new Oncologic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.